Hao C., Cao M., Ouyang H., Chen Z., Hu G., Li Q. Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents. Future Med. Chem., 2023, 15(5): 453-465.
Hits:
|
Pre One:Hu L., Zhao C., Chen Z., Hu G., Li X., Li Q. An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition. Drug Discov Today, 2022, 27(5): 1457-1463.
Next One:He Y., Le X., Hu G., Li Q., Chen Z. Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer. Pharmaceuticals (Basel), 2023, 16(2).
